These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35461262)

  • 41. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME
    N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
    Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
    J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.
    Husain MI; Chaudhry IB; Rahman RR; Hamirani MM; Qurashi I; Khoso AB; Deakin JF; Husain N; Young AH
    Trials; 2015 Sep; 16():410. PubMed ID: 26374703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scopolamine as an antidepressant: a systematic review.
    Jaffe RJ; Novakovic V; Peselow ED
    Clin Neuropharmacol; 2013; 36(1):24-6. PubMed ID: 23334071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Bauer MS; Wisniewski SR; Marangell LB; Chessick CA; Allen MH; Dennehy EB; Miklowitz DJ; Thase ME; Sachs GS
    J Clin Psychiatry; 2006 Jan; 67(1):48-55. PubMed ID: 16426088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of smartphone-based ambulatory assessment (SBAA-BD) including a predicting system for upcoming episodes in the long-term treatment of patients with bipolar disorders: study protocol for a randomized controlled single-blind trial.
    Mühlbauer E; Bauer M; Ebner-Priemer U; Ritter P; Hill H; Beier F; Kleindienst N; Severus E
    BMC Psychiatry; 2018 Oct; 18(1):349. PubMed ID: 30367608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
    Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
    Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.
    Zeinoddini A; Sorayani M; Hassanzadeh E; Arbabi M; Farokhnia M; Salimi S; Ghaleiha A; Akhondzadeh S
    Depress Anxiety; 2015 Mar; 32(3):167-73. PubMed ID: 25620378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.
    Lazowski LK; Townsend B; Hawken ER; Jokic R; du Toit R; Milev R
    BMC Psychiatry; 2014 Jul; 14():202. PubMed ID: 25030264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: study protocol.
    Douglas KM; Inder ML; Crowe MT; Jordan J; Carlye D; Lacey C; Beaglehole B; Mulder R; Eggleston K; Donovan KA; Frampton CMA; Bowie CR; Porter RJ
    BMC Psychiatry; 2022 Feb; 22(1):115. PubMed ID: 35164720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
    Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
    CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
    Keck PE; Calabrese JR; McIntyre RS; McQuade RD; Carson WH; Eudicone JM; Carlson BX; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2007 Oct; 68(10):1480-91. PubMed ID: 17960961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.